Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly ended its bear phase, with shares rising 12% to over $650 after reporting a 0.8% revenue increase to $3.75 billion.
- Strong sales of Dupixent, totaling $4.9 billion, offset weak EYLEA sales.
- EYLEA HD sales grew 42% to $663 million.
- The firm lowered its R&D and SG&A expense forecast for the fiscal year.
UPS, despite being down 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion.
- UPS announced a massive 48,000 job cut, with 34,000 in operational units and 14,000 at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with an 11% loss in stock value.
No direct quotes available in the text.
Author's summary: Stocks show mixed results with Regeneron rising and Zebra falling.
More News
- When a Victorian ghost hunter investigated Britain’s most haunted house, this is what he found
- And the Winner Is… The Local’s 2nd Annual Halloween Decorating Showdown Champion
- NBA approves $10 billion Lakers sale to Mark Walter
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- The Knicks are seeing the true value of Miles McBride during his absence
- Romero Elementary stage shines with creativity at pumpkin decorating contest
- CULTURE CLUB: Peninsula Music Festival: Balancing the Baton - Door County Pulse
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- Halloween decorating contest winners announced
- O Canada! Summer tourism numbers hit all-time high | RCI